Literature DB >> 9203940

Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease.

J M Evans1, A D McMahon, F E Murray, D G McDevitt, T M MacDonald.   

Abstract

BACKGROUND: To evaluate the relation between non-steroidal anti-inflammatory drugs (NSAIDs) and colitis due to inflammatory bowel disease.
METHODS: A case-control study was conducted using a prospectively constructed, record linkage database containing hospital event and dispensed drug data (1989-93). The study population consisted of 319,465 people resident in Tayside in January 1989, and still resident (or dead) in October 1994.
RESULTS: Of the 785 patients admitted to hospital as emergencies with colitis between July 1989 and June 1993, 200 fulfilled the case criterion of colitis due to inflammatory bowel disease. A further 1198 persons were used as community controls. Odds ratios were calculated for three exposure periods (current, recent, and past exposure). The overall odds ratios (with 95% confidence intervals) for current and recent exposure to NSAIDs were 1.77 (1.01 to 3.10) and 1.93 (1.20 to 3.09) respectively. Current and recent exposure to NSAIDs was also associated for incident cases, with odds ratios of 2.96 (1.32 to 6.64) and 2.51 (1.13 to 5.55). There was a trend for recent exposure among non-incident cases.
CONCLUSION: The use of NSAIDs may be associated with an increased risk of emergency admission to hospital for colitis due to inflammatory bowel disease, particularly among patients with no previous history.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203940      PMCID: PMC1027164          DOI: 10.1136/gut.40.5.619

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

1.  Data torturing.

Authors:  J L Mills
Journal:  N Engl J Med       Date:  1993-10-14       Impact factor: 91.245

Review 2.  Selection of cases and controls.

Authors:  T Lasky; P D Stolley
Journal:  Epidemiol Rev       Date:  1994       Impact factor: 6.222

3.  Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

Authors:  L A García Rodríguez; H Jick
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

4.  Colitis associated with non-steroidal anti-inflammatory drugs.

Authors:  M Gleeson; D Ramsay; S Hutchinson; D Spencer; G Monteith
Journal:  Lancet       Date:  1994-10-08       Impact factor: 79.321

5.  Colitis associated with non-steroidal anti-inflammatory drugs.

Authors:  R P Walt; C J Hawkey; M J Langman
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-21

6.  Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure.

Authors:  J M Evans; E McGregor; A D McMahon; M M McGilchrist; M C Jones; G White; D G McDevitt; T M MacDonald
Journal:  QJM       Date:  1995-08

Review 7.  Colitis induced by nonsteroidal anti-inflammatory drugs. Report of four cases and review of the literature.

Authors:  G R Gibson; E B Whitacre; C A Ricotti
Journal:  Arch Intern Med       Date:  1992-03

8.  Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study.

Authors:  J M Evans; A D McMahon; M M McGilchrist; G White; F E Murray; D G McDevitt; T M MacDonald
Journal:  BMJ       Date:  1995-07-01

9.  Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease.

Authors:  H J Kaufmann; H L Taubin
Journal:  Ann Intern Med       Date:  1987-10       Impact factor: 25.391

10.  Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs.

Authors:  M J Langman; J Weil; P Wainwright; D H Lawson; M D Rawlins; R F Logan; M Murphy; M P Vessey; D G Colin-Jones
Journal:  Lancet       Date:  1994-04-30       Impact factor: 79.321

View more
  43 in total

Review 1.  Record-linkage for pharmacovigilance in Scotland.

Authors:  J M Evans; T M MacDonald
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

Review 2.  Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease.

Authors:  J R Korzenik; B K Dieckgraefe
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

Review 3.  Small therapeutic molecules for the treatment of inflammatory bowel disease.

Authors:  S J H van Deventer
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

Review 4.  Current concept of pathophysiological understanding and natural course of ulcerative colitis.

Authors:  Martin H Holtmann; Peter R Galle
Journal:  Langenbecks Arch Surg       Date:  2004-02-04       Impact factor: 3.445

5.  Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease.

Authors:  Millie D Long; Michael D Kappelman; Christopher F Martin; Wenli Chen; Kristen Anton; Robert S Sandler
Journal:  J Clin Gastroenterol       Date:  2016-02       Impact factor: 3.062

Review 6.  Indeterminate colitis.

Authors:  M Guindi; R H Riddell
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

7.  Appendectomy, tonsillectomy, and risk of inflammatory bowel disease: a case control study in Iran.

Authors:  Farzad Firouzi; Ali Bahari; Rahim Aghazadeh; Mohammad Reza Zali
Journal:  Int J Colorectal Dis       Date:  2005-06-04       Impact factor: 2.571

8.  European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Authors:  R Caprilli; M A Gassull; J C Escher; G Moser; P Munkholm; A Forbes; D W Hommes; H Lochs; E Angelucci; A Cocco; B Vucelic; H Hildebrand; S Kolacek; L Riis; M Lukas; R de Franchis; M Hamilton; G Jantschek; P Michetti; C O'Morain; M M Anwar; J L Freitas; I A Mouzas; F Baert; R Mitchell; C J Hawkey
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

9.  L-carnitine, a diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation.

Authors:  G Fortin; K Yurchenko; C Collette; M Rubio; A-C Villani; A Bitton; M Sarfati; D Franchimont
Journal:  Clin Exp Immunol       Date:  2009-01-23       Impact factor: 4.330

10.  Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs.

Authors:  E Smecuol; J C Bai; E Sugai; H Vazquez; S Niveloni; S Pedreira; E Mauriño; J Meddings
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.